Showing results (51-60 of 160) with videos related to
Sort By:
Pageof 16
Basic Research in Cardiology|January 1, 1989
Cardiovascular effects of forskolin and phosphodiesterase-III inhibitorsM Schlepper, J Thormann, V MitrovicArzneimittel-Forschung|January 1, 1976
[Changes in hemodynamics and contractility during supraventricular tachycardias and after electrical or aprindin-induced termination (author's transl)]H G Weppner, H Merle, M SchlepperCardiovascular Research|January 1, 1978
Haemodynamic effects of supraventricular tachycardias and their alterations by electrically and verapamil induced terminationM Schlepper, H G Weppner, H MerlePacing and Clinical Electrophysiology : PACE|March 1, 1995
Programmable VT detection enhancements in implantable cardioverter defibrillator therapyJ Neuzner, H F Pitschner, M SchlepperHerz|October 1, 1994
[Indications and contraindications for therapy with implantable cardioverters/defibrillators]J Neuzner, H F Pitschner, M SchlepperDeutsche Medizinische Wochenschrift (1946)|January 3, 1975
[Left atrial lead and stimulation in wpw-syndrome type A (author's transl)]H Neuss, H F Spiess, K D GrosserCardiovascular Drugs and Therapy|December 1, 1991
Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertensionV Mitrovic, W Patyna, J Hüting, et al.Zeitschrift Fur Kardiologie|November 1, 1977
[Left ventricular ejection and ejection reserve during isoproterenol infusion in hypertrophic obstructive cardiomyopathy (author's transl)]R Ensslen, F Schwarz, J Thormann, et al.Zeitschrift Fur Kardiologie|November 1, 1982
[Mechanism and effects of the cardiotonic AR-L 115 BS in coronary heart disease: improved ventricular function and regional wall motility without angina pectoris]J Thormann, M Schlepper, W Kramer, et al.Cardiovascular Drugs and Therapy|April 1, 1989
Influence of the new class I antiarrhythmic agent diprafenone on the end-systolic pressure-volume relationship (conductance technique)J Thormann, W Kramer, P Kremer, et al.Pageof 16